| 31 |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
|
2021 |
| 32 |
HLA-B* 15 predicts survival in Egyptian patients with COVID-19 |
2021 |
| 33 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 34 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 35 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 36 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 37 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 38 |
Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues |
2021 |
| 39 |
Micro-RNA 155 in non-Hodgkin lymphoma |
2021 |
| 40 |
Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients |
2021 |
